CE-marked EVOQUE valve system, a breakthrough for tricuspid valve replacement. Edwards Lifesciences Corporation has officially announced that their EVOQUE tricuspid valve replacement system has received CE Mark approval for transcatheter treatment of patients with tricuspid regurgitation (TR). This achievement marks a significant milestone, as the EVOQUE system becomes the world’s Leggi tutto…
Medtronic, a global leader in healthcare technology, proudly announced the CE (Conformité Européenne) mark approval for its innovative Simplera™ all-in-one disposable continuous glucose monitor (CGM). This device features a two-step insertion process, eliminating the need for adhesive tape. Simplera™ has been designed to provide a comprehensive solution that seamlessly integrates Leggi tutto…
The US Food and Drug Administration (FDA) has approved what is now the third generation of the MitraClip system for transcatheter-based mitral valve repair, Abbott Vascular announced in a news release today. “The next-generation MitraClip system provides cardiologists with advanced steering, navigation, and positioning capabilities for the clip, making it easier to use in Leggi tutto…